Clinical Efficacy of Human Papilloma Virus DNA Test Using Hybrid Capture System in Health Screening of Normal Women.
- Author:
Ok Kyoung MIN
;
Jong Sup PARK
;
Chan Ju KIM
;
Dong Choon PARK
;
Hye Kyoung YANG
;
Seong Hie NOH
;
Sung Eun NAMKOONG
;
Seung Jo KIM
- Publication Type:Original Article
- Keywords:
Cervical cancer screening;
cytology HPV(human papillomavirus);
Hybrid Capture System
- MeSH:
Delivery of Health Care;
DNA*;
Female;
Humans*;
Mass Screening*;
Papilloma*;
Uterine Cervical Neoplasms
- From:Korean Journal of Gynecologic Oncology and Colposcopy
1996;7(3):199-207
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Cervical cancer and its precursors are caused principally, if not exclusively, by HPV infection and HPV DNA is found in more than 90% of cervical cancers. Cervical cytology is limited by its false negativity and this may be supplimented by other adjunctive test such as HPV test. It is therefore important to explore the use of HPV DNA detection as a primary or supplementary screening method and to determine whether HPV typing can be used as a predictor of a lesion's clinical behavior. Cervical cytology and Hybrid Capture test for HPV detection were performed in 450 asymtomatic wornen visited Health Care Center in Kangnam St. Mary's Hospital,and none of whom was believed to have current cervical disease. The Papanicolaou cytology results were classified by The Bethesda System : 333(74.%) women were classified to within normal limit, 19(4.2%) benign reactive change, 38(8.4%) ASCUS, 59(13%) low grade SIL, and only one woman high grade SIL. Twenty five of 450(5.6%) women showed HPV infection by Hybid Capture test. Among 98 wornen with abnormal Papanicolaou cytology, 16(16.3%) women showed HPV DNA positivity. (continue)
